home
pharmaindex
generic indexcompaniesmedical actsmedicalcollege

List of Approved Drug for Marketing in India in the
Year 2017

S. NO APPROVED DRUG INDICATION APPROVAL DATE
1. Hydrocortisone Aceponate 0.584mg/ml Cutaneous Spray Solution (Vet.) For symptomatic treatment of inflammatory and pruritic dermatosis in dogs. 06.01.17
2. Dexlansoprazole Delayed Release Capsule 30/60mg & Bulk

For the treatment of

i)  Healing of all grades of erosive esophagitis (EE).

ii)  Maintaining healing of EE and relief of heartburn.

iii)  Treating heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD).

16.01.17
3. Carfilzomib Sterile Lyophilized Powder for Injection 60mg/vial (50ml vial)

Relapsed or refractory multiple myeloma

  • Carfilzomib for injection is indicated in combination with dexamethasone or with lenalidomide plus dexamethasone for the treatment of patients with relapsed or refractory multiple myeloma who have received one to three lines of therapy.
  • Carfilzomib for injection is indicated as a single agent for the treatment of patients with relapsed or refractory multiple myeloma who have received one or more lines of therapy.
17.01.17
4.

Dabrafenib 50mg/75mg Capsules

(Dabrafenib Mesylate)

As a single agent for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an appropriate test.

In combination with Trametinib for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an appropriate test.

18.01.17
5.

Trametinib 0.5mg/2mg Tablets

(Trametinib Dimethyl Sulfoxide)

As a monotherapy and in combination with Dabrafenib for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an appropriate test. 18.01.17
6. Alectinib 150mg Capsules (Alectinib Hydrochloride) For the treatment of patients with anaplastic lymphoma kinase (ALK)-Positive, metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to Crizotinib. 23.01.17
7.

Eliglustat 84mg Capsules

(Eliglustat Tartrate or Hemitartrate Salt)

For the long term treatment of adult patients with Gaucher disease type 1 who are CYP2D6 extensive metabolizers (EMs), intermediate metabolizers (IMs), or poor metabolizers (PMs) as detected by an appropriate test. 31.01.17

 

 

Advertisement

Important Links



Copyright ©2007-2016. medline india. All rights reserved.

Content on this web site is for informational purpose only. It is not intended to provide medical or other professional advice.